CG
GBIO

Carmignac Gestion’s Generation Bio GBIO Stock Holding History

Carmignac Gestion’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-147,262
Closed -$36.9M – 130
2021
Q3 		$36.9M Sell
147,262
-90
-0.1% -$21.6K 0.46% 45
2021
Q2 		$39.6M Sell
147,352
-6,222
-4% -$1.86M 0.46% 47
2021
Q1 		$43.7M Buy
+153,574
New +$49.2M 0.5% 48

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
YCM
Yiheng Capital Management San Francisco, California $231M AUM 29.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Carmignac Gestion's GBIO Position: Q4 2021 in Review

Carmignac Gestion sold out of Generation Bio (GBIO) in Q4 2021, closing a stake of 147,262 shares — an estimated $36.9M sold.

Carmignac Gestion first reported a position in GBIO in Q1 2021 and held it in 3 quarters. The position peaked at $43.7M in Q1 2021. 88 funds tracked by Wall St. Rank hold GBIO as of Q4 2021.

  • Carmignac Gestion reported no remaining Generation Bio position as of Q4 2021 after selling out during the quarter.
  • Carmignac Gestion sold 147,262 Generation Bio shares in Q4 2021, an estimated $36.9M.
  • Carmignac Gestion first reported a position in Generation Bio in Q1 2021 and held it in 3 quarters.
  • Carmignac Gestion's Generation Bio position peaked at $43.7M in Q1 2021.
  • 88 funds tracked by Wall St. Rank held Generation Bio as of Q4 2021.

Based on Carmignac Gestion's 13F filing for Q4 2021, filed 11 Feb 2022.